well
known
lung
asthmat
show
airway
wall
remodel
asthma
exacerb
link
respiratori
infect
evid
respiratori
infect
earli
childhood
may
increas
risk
develop
asthma
later
life
chronic
obstruct
pulmonari
diseas
copd
definit
involv
structur
chang
airway
howev
littl
known
role
viru
infect
play
develop
remodel
review
consid
role
matrix
metalloproteas
neutrophil
elastas
remodel
whether
induct
proteas
mediat
respiratori
viru
infect
may
contribut
develop
airway
remodel
q
airway
remodel
ar
common
asthmat
clinic
present
airflow
obstruct
poorli
revers
bronchodil
laboratori
find
includ
greater
thick
airway
wall
subepitheli
layer
smooth
muscl
hyperplasia
goblet
epitheli
cell
structur
chang
may
also
contribut
worsen
bronchial
hyperresponsiv
ar
may
partli
explain
lung
function
declin
rapidli
asthmat
nonasthmat
ar
difficult
studi
without
invas
costli
imag
procedur
conflict
data
revers
ar
corticosteroid
treatment
durat
dose
treatment
durat
diseas
time
start
treatment
impact
result
despit
grow
consensu
ar
import
compon
asthma
amelior
remodel
import
therapeut
outcom
molecular
basi
process
remain
obscur
chronic
obstruct
pulmonari
diseas
copd
collect
term
degen
obstruct
lung
diseas
overwhelmingli
due
cigarett
smoke
copd
includ
emphysema
chronic
bronchiti
chronic
obstruct
bronchiol
much
variat
lung
patholog
copd
typic
featur
alveolar
destruct
lead
perman
peripher
airspac
enlarg
small
airway
fibrosi
increas
number
inflammatori
cell
small
airway
reduc
lung
elast
increas
mucu
product
declin
lung
function
poorli
revers
bronchodil
contribut
factor
ar
includ
excess
proteas
activ
free
radic
damag
follow
induct
growth
factor
presum
aberr
repair
process
may
worsen
polymorph
enzym
metabol
cigarett
smoke
compon
asthma
copd
viral
infect
commonli
precipit
sever
sustain
diseas
exacerb
respiratori
virus
detect
patient
acut
exacerb
copd
respiratori
virus
detect
school
age
children
acut
exacerb
asthma
amongst
adult
asthmat
patient
requir
emerg
treatment
acut
asthma
infect
respiratori
viru
copd
exacerb
link
worsen
qualiti
life
rapid
declin
lung
function
frequent
longer
last
hospit
admiss
typic
virus
known
caus
exacerb
rhinovirus
caus
common
cold
follow
respiratori
syncyti
viru
rsv
influenza
coronavirus
parainfluenza
virus
piv
addit
hogg
propos
latent
adenoviru
infect
might
also
contribut
pathogenesi
copd
detect
rate
preval
specif
virus
vari
patient
age
time
year
site
sampl
method
detect
influenza
vaccin
statu
year
predomin
influenza
strain
particular
older
studi
use
cultur
andor
serolog
lower
viru
detect
rate
pcr
use
respiratori
symptom
similar
infect
pathogen
distinct
virus
differ
replic
strategi
littl
known
respiratori
viru
infect
worsen
asthma
copd
landmark
studi
corn
et
al
found
asthmat
like
get
rhinoviru
cold
nonasthmat
domest
partner
asthmat
like
develop
lower
respiratori
tract
symptom
sever
long
last
possibl
mediat
proteas
induc
respiratori
viru
infect
contribut
sever
diseas
patient
review
discuss
limit
knowledg
induct
proteas
respiratori
viru
infect
potenti
role
respiratori
virus
ar
known
proteas
inhibitor
inflammatori
lung
diseas
briefli
address
detail
reader
consult
review
studi
specif
address
issu
knowledg
three
studi
topic
variabl
result
point
need
research
guinea
pig
infect
rsv
develop
viral
bronchiol
day
rsv
infect
guinea
pig
significantli
increas
eosinophilia
airway
hyperrespons
ahr
viru
infect
guinea
pig
control
signific
differ
thick
subepitheli
connect
tissu
smooth
muscl
infect
anim
may
need
kept
longer
time
remodel
appar
although
evid
occup
asthma
research
remodel
human
occur
fairli
shortterm
exposur
allergen
rsv
infect
airway
epitheli
cell
secret
increas
amount
basic
fibroblast
growth
factor
bfgf
comparison
uninfect
cell
could
contribut
remodel
mice
infect
sendai
viru
paramyxoviru
natur
rodent
pathogen
moder
relat
rsv
piv
acut
chronic
airway
hyperreact
viru
undetect
cultur
day
postinfect
pi
real
time
pcr
day
pi
increas
number
mucusproduc
goblet
cell
increas
stain
mucin
seen
day
pi
similar
profil
acut
fatal
asthma
human
increas
airway
hyperreact
goblet
cell
hyperplasia
partli
reduc
corticosteroid
unchang
ifng
knockout
mice
author
interpret
overal
find
mean
singl
viru
infect
lead
perman
chang
epithelium
airway
chronic
phenotyp
mice
genet
segreg
acut
antivir
respons
first
glanc
seem
odd
proteas
contribut
ar
main
task
degrad
protein
howev
increas
proteas
activ
major
impact
overal
level
inflamm
least
matrix
metalloproteas
mmp
secret
associ
cell
membran
mmp
constitut
express
healthi
tissu
gener
epitheli
surfac
secret
mmp
express
tissu
undergo
angiogenesi
diseas
inflamm
repair
contrast
mrna
six
membranetyp
mmp
constitut
express
mani
normal
cell
tissu
includ
leukocyt
lung
spleen
older
paper
name
mmp
reflect
best
studi
substrat
wherea
recent
terminolog
use
number
mani
mmp
cleav
multipl
substrat
exampl
gelatinas
b
respect
known
import
lung
normal
made
resid
lung
cell
made
leukocyt
bronchial
epitheli
cell
cell
type
respons
variou
stimuli
macrophag
neutrophil
lymphocyt
fibroblast
smooth
muscl
cell
produc
rang
mmp
depend
stimulu
detail
mmp
role
normal
diseas
lung
found
recent
review
activ
mmp
control
four
level
gene
express
compartment
eg
anchor
mmp
cell
membran
neutrophil
store
mmp
granul
proteolysi
cleav
pro
region
mmp
serin
proteas
enzym
inactiv
eg
bind
endogen
inhibitor
activ
process
influenc
inflammatori
mediat
anchor
mmp
cell
surfac
provid
better
control
proteolysi
addit
proteas
design
membranetyp
mmp
cell
surfac
associ
human
neutrophil
report
five
known
tissu
inhibitor
metalloproteas
timp
asid
main
role
mmp
regul
timp
also
involv
regul
proteas
apoptosi
henc
least
transient
dysregul
timp
asthma
copd
could
system
impact
inhibitor
exist
main
circul
inhibitor
macroglobulin
studi
mmp
bodi
fluid
must
consid
mmp
may
complex
inhibitor
neutrophil
elastas
ne
serin
proteas
critic
antimicrobi
activ
neutrophil
serin
proteas
relev
copd
proteinas
cathepsin
g
ne
store
primari
azurophil
granul
releas
upon
neutrophil
degranul
degrad
almost
extracellular
matrix
protein
key
plasma
protein
well
innat
immun
protein
complement
receptor
lung
surfact
protein
ne
gener
proinflammatori
molecul
also
turn
inflamm
cleavag
proinflammatori
cytokin
main
endogen
inhibitor
ne
proteas
inhibitor
macroglobulin
secretori
leukocyt
proteas
inhibitor
slpi
increas
net
activ
ne
seen
acut
lung
injuri
acut
viral
exacerb
asthma
copd
stimul
releas
mucu
strongli
link
alveolar
destruct
collagenas
macrophag
metalloelastas
also
implic
alveolar
destruct
vitro
studi
provid
indirect
evid
involv
migrat
lymphocyt
eosinophil
neutrophil
across
basement
membran
elastas
contribut
process
activ
proform
involv
certain
proteas
process
mean
essenti
redund
proteas
mice
need
neutrophil
migrat
lung
vitro
neutrophil
bacteriocid
activ
inde
mice
knockout
specif
mmp
normal
unchalleng
redund
could
limit
therapeut
use
proteas
inhibitor
mani
studi
proteas
inhibitor
asthma
copd
gener
pictur
higher
overal
proteas
activ
specif
conclus
depend
site
sampl
bronchoalveolar
lavag
bal
sputum
nasopharyng
aspir
immunohistochemistri
lung
biopsi
method
assay
stimulu
patient
deriv
cell
use
vitro
studi
patient
statu
time
sampl
stabl
exacerb
medic
use
smoke
statu
natur
control
patient
recoveri
healthi
control
healthi
smoker
increas
proteas
activ
observ
studi
need
mean
inhibitor
concurr
downregul
studi
directli
look
proteas
remodel
mice
sensit
ovalbumin
challeng
aerosol
ovalbumin
upregul
bal
accompani
infiltr
eosinophil
lymphocyt
movement
cell
airway
lumen
inhibit
treat
mice
subsequ
histolog
studi
show
epitheli
basement
membran
damag
transmigr
inflammatori
cell
furthermor
treatment
mice
dexamethason
greatli
reduc
transmigr
inflammatori
cell
damag
epitheli
basement
membran
basi
vitro
properti
mani
growth
factor
inflammatori
mediat
implic
ar
possibl
mediat
includ
tgfb
plateletderiv
growth
factor
bfgf
tnfa
relev
properti
mitogen
activ
fibroblast
andor
airway
smooth
muscl
cell
promot
connect
tissu
synthesi
cell
mmp
directli
impact
activ
growth
factor
chemokin
tgfb
tnfa
insulinlik
growth
factor
igf
egf
fgf
monocyt
chemoattract
protein
mcp
product
mmp
activ
act
chemoattract
intratrach
instil
elastas
mice
led
timedepend
releas
tgfb
lung
bal
much
tgfb
activ
form
pulmonari
fibroblast
cultur
elastas
treatment
caus
releas
tgfb
adult
respiratori
viru
infect
acut
exacerb
asthma
increas
sputum
neutrophil
increas
neutrophil
elastas
compar
baselin
sampl
week
later
virus
main
caus
copd
exacerb
mani
patient
stabl
copd
show
colon
normal
steril
lower
airway
potenti
pathogen
bacteria
risk
factor
frequent
sever
exacerb
copd
matrilysin
rapidli
induc
airway
epitheli
cell
expos
bacteria
activ
antibacteri
defenc
could
contribut
remodel
inflammatori
lung
diseas
respiratori
viru
infect
induc
key
lung
proteas
viral
exacerb
could
lead
hyperinduct
activ
proteas
acceler
remodel
pubm
search
mmp
viru
word
titleabstract
yield
hit
focuss
actual
induct
mmp
viru
distinct
use
viral
vector
gene
express
mostli
limit
hepat
virus
neurotrop
virus
retrovirus
hiv
coxsacki
viru
infect
weanl
balbc
mice
associ
cardiac
fibrosi
week
pi
none
virus
close
relat
common
respiratori
virus
knowledg
three
studi
look
induct
mmp
upon
infect
respiratori
virus
mdck
cell
dog
kidney
vero
cell
monkey
kidney
support
growth
influenza
virus
zymographi
run
biolog
fluid
bal
gel
contain
proteas
substrat
show
influenza
infect
mdck
secret
less
uninfect
cell
infect
vero
cell
activ
unaffect
activ
increas
slightli
level
mdck
cell
unaffect
influenza
vero
cell
influenza
infect
caus
fold
increas
peak
viru
infect
influenza
shut
synthesi
host
cell
protein
must
consid
measur
mediat
infect
cell
anim
influenza
infect
human
caus
signific
patholog
lower
respiratori
tract
common
featur
includ
desquam
epithelium
mucos
oedema
leukocyt
infiltr
complex
process
feasibl
host
proteas
involv
proteas
could
trigger
detach
epitheli
monolay
basement
membran
may
serv
limit
viru
spread
although
dead
infect
cell
still
trigger
inflamm
rsvinfect
human
airway
epithelium
cell
show
secret
cell
surfac
associ
uninfect
cell
inhibitor
significantli
reduc
rsv
replic
inhibitor
ad
earli
infect
rsv
mostli
spread
celltocel
fusion
form
characterist
giant
cell
syncytia
although
extracellular
spread
occur
enlarg
syncytia
seen
transfect
overexpress
smaller
syncytia
seen
transfect
overexpress
data
suggest
role
virusinduc
viru
spread
possibl
enhanc
activ
rsvinfect
cell
may
facilit
cellcel
spread
vivo
one
specul
rsvinduc
proteas
contribut
spread
viru
upper
lower
respiratori
tract
seen
infant
rsv
cytopatholog
cell
enhanc
trypsin
thrombin
plasmin
although
known
enhanc
cytopatholog
link
higher
viru
titr
precis
mechan
rsv
spread
unknown
great
interest
sinc
poor
immun
respons
rsv
human
lead
persist
reinfect
effect
drug
treat
rsv
vivo
studi
proteas
induct
respiratori
viru
look
arteriviru
porcin
reproduct
respiratori
syndrom
viru
prrsv
piglet
bal
serum
infect
piglet
significantli
increas
activ
peak
day
correl
well
viru
replic
lung
histolog
lesion
increas
monocyt
lymphocyt
level
return
normal
week
pi
direct
vivo
studi
role
mmp
ar
respons
viral
infect
infer
follow
sequenc
observ
infect
respiratori
virus
rsv
influenza
induc
proinflammatori
cytokin
tnfa
stimul
product
releas
cleav
elastin
elastinderiv
peptid
chemotact
monocyt
lesser
extent
neutrophil
alveolar
macrophag
elastinderiv
peptid
made
human
neutrophil
elastas
digest
elastin
chemotact
fibroblast
mani
mmp
inhibitor
exist
sinc
mmp
structur
similar
inhibitor
often
specif
enough
therapeut
use
furthermor
mani
mmp
overlap
cellular
function
multipl
mmp
upregul
mani
diseas
state
least
mice
broad
mmp
inhibit
harm
cancer
patient
treat
broad
spectrum
mmp
inhibitor
develop
revers
skin
thicken
shorten
muscl
tissu
joint
specif
ne
inhibitor
effect
treat
acut
lung
injuri
anim
human
upregul
mmp
seen
hivassoci
neurolog
diseas
interest
clinic
use
antihiv
drug
reduc
mmp
activ
lipopolysaccharid
stimul
brain
cell
patient
asthma
copd
often
sever
affect
respiratori
viru
infect
gener
popul
ar
contribut
lung
dysfunct
asthma
copd
littl
research
done
area
possibl
lung
proteas
factor
ar
mani
trigger
lead
net
increas
activ
rang
lung
proteas
possibl
role
respiratori
viru
infect
increas
lung
proteas
level
deserv
studi
